Back

Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: implications of insulin treatment: a report from the GLORIA-AF Registry Phase III

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Integrated management of atrial fibrillation: addressing comorbidities, risk factors, and lifestyle Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Bi Huang

The First Affiliated Hospital of Chongqing Medical University, Chongqing (China)

5 More presentations in this session

Presentation thumbnail
Adherence to the ABC pathway improves prognosis in patients with AF: preliminary findings from an updated meta-analysis of 360,000 patients
Doctor G. Romiti (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Outcome and life expectancy associated with novel subgroups of atrial fibrillation: a data-driven cluster analysis
Doctor Y. Yu (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Impact of blood pressure control on the risk of stroke and mortality in patients with atrial fibrillation across different ages: a nationwide population-based study
Doctor M. Jeong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Body mass index may alter cardiovascular outcomes in patients with newly-diagnosed atrial fibrillation and previous stroke: an interaction analysis using longitudinal data from the GLORIA-AF registry
Doctor S. Lam (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Effects of mineralocorticoid receptor antagonists on new-onset or recurrent atrial fibrillation: a Bayesian and frequentist network meta-analysis of randomized trials.
Doctor P. Karakasis (Thessaloniki, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Integrated management of atrial fibrillation: addressing comorbidities, risk factors, and lifestyle
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources